This is the authors' abstract. We don't add key points for this paper.
To the Editor: The oxidation of butyrate, a colonic metabolite of carbohydrates and the major energy source for the colonic mucosa, is impaired in ulcerative colitis (UC) due to defects in butyrate transport across the epithelium and the butyrate oxidation pathway.1,2 This deficiency is initiated at the gene expression level and is the result of a decreased expression of the butyrate transporter (SLC16A1, also known as monocarboxylic acid transporter 1 (MCT1)), and the enzymes involved in the β-oxidation pathway of butyrate.3 In Crohn's disease (CD), the colonic mucosal metabolism of butyrate has been studied to a lesser extent. Duffy et al4 described an inflammation-dependent decrease in butyrate oxidation in patients with Crohn's colitis, whereas Jorgensen and Mortensen5 did not find an impaired metabolism in CD. To evaluate whether a deficiency in the butyrate metabolism is also present in CD at the gene expression level, we explored the expression of the corresponding genes in the colonic mucosa from patients with CD.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Preter et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: